bpc 157 interaction with antidepressants Does BPC-157 Cause Insomnia? Peptides Antidepressants Combine Safe —

doi:10.1186/s12894-019-0492-2

Hepatic cytochrome P450 isoenzymes CYP1A2 and CYP3A4 mediate N-de-ethylation, so polymorphisms or competitive inhibition at these pathways (e.g., by certain antidepressants or azole antifungals) may increase systemic exposure, underscoring the importance of individualizing dosage and monitoring serum concentrations in prolonged infusions

Peptide Therapy is considered safe when prescribed and monitored by a qualified medical professional

Glucose disturbances occur in up to 90% of patients with Cushings syndrome (CS), with overt diabetes in 50% and glucose intolerance in up to 30% [181]

Serum B12 peaks 2448 hours post-injection and sustains elevated levels for approximately 34 weeks